new BindingDB logo
myBDB logout

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28650658 54 Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.EBI Shandong University
26428871 11 Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.EBI Sichuan University
25893041 12 Discovery of a Dual PRMT5-PRMT7 Inhibitor.EBI University of Toronto
25559100 25 Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.EBI The University of Georgia
25032507 43 Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI University of North Carolina at Chapel Hill
24564570 12 Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.EBI The University of Georgia
23433670 15 Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.EBI EntreMed Inc.
24900432 51 Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.EBI TBA
22749641 15 Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents.EBI Georgia State University
29019697 24 Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation.EBI Zhejiang Sci-Tech University
28135235 71 An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.BDB Novartis Institutes for BioMedical Research
17705362 43 Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.BDB Ligand Pharmaceuticals Inc.